BCAT BCAT
Company Profile ↓Company Overview
BCAT (BCAT) is a publicly traded company listed on with a market capitalization of $1.68B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 8.7.
Maintains a net profit margin of 99.3%.
Carries low leverage with a debt-to-equity ratio of 0.11.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $223.60M (+13.1% YoY); net profit $221.99M.
- Trailing 12 Months Year-on-year growth — revenue +13.1%, earnings +14.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 13.12% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 14.18% |
Stock Price Performance
| 1 Year: | +30.82% |
| 6 Months: | +17.28% |
| 3 Months: | +8.59% |
| 1 Month: | +1.85% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.94 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 99.3%.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | -320.36M | 206.90M | 197.67M | 223.60M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 2.16M | 2.18M | 3.25M | 1.61M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 2.90M | 1.40M | 1.40M | 1.43M |
| Pretax Income | - | -322.52M | 204.72M | 194.42M | 221.99M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -322.52M | 204.72M | 194.42M | 221.99M |
| Diluted EPS | 1.10 | -2.81 | 1.92 | 1.83 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 2.25B | 2.05B | 1.92B | 1.97B |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 4.10M | 6.93M | 6.30M | 6.75M |
| Inventory | - | - | - | - | - |
| Receivables | - | 154.46M | 30.22M | 11.13M | 101.18M |
| Total Liabilities | - | 431.98M | 194.62M | 203.05M | 370.43M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | 690.56M | 1.80M | - | - | - |
| Total Equity | - | 1.82B | 1.85B | 1.72B | 1.60B |
| Shares Outstanding | - | 108.14M | 107.46M | 104.78M | 104.78M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 867.86M | 181.33M | 354.89M | 329.51M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | -879.91M | -177.59M | -326.85M | -344.70M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | 867.86M | 181.33M | 354.89M | 329.51M |
| Net Change in Cash | - | -12.05M | 3.73M | 28.03M | -15.19M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 100.7% | 98.9% | 98.4% | 99.3% |
| ROE % | - | -17.7% | 11.0% | 11.3% | 13.9% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for BCAT
BCAT | BlackRock Capital Allocation Term Insider Trading - quiverquant.com
<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFAzX081WHFQa0tBcUZLbVFvYWxBMkM3cDhOOWNIcjlCZVN3U2lBNkJlYVBleDBkVkZmUGZWTmJ5OHhKdGpLcFdHQ0M2aUkwczR4T0x2SE8yUHZsOHFO?oc=5" target="_blank">BCAT | BlackRock Capital Allocation Term In…
BlackRock Capital Allocation Term Trust (BCAT) - Live Price & How to Invest from India - INDmoney
<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE5nZ0piYjRGY1FIVlNaZ2pKUTJwVE5hdlpSanBYRTc5XzNZY2JZQl9FUEROcloxaVNxYlZLOV8wRk84alhIM2VSU3Z6czJaWGFjUktpeDR1bw?oc=5" target="_blank">BlackRock Capital Allocation Term Trust (BCAT) - …
Understanding Momentum Shifts in (BCAT) - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOcTdmYnAyMkhDRjcxdWFtUjhwWWVkcGZiMjVtZ3M0WGxNalJ4c193YjkzazV3dzNsY2dTZ3M3QjJOV0tZOHhmNmRZVk9jQzBtRFltSVp3OWt2Y0lyb2RUQTU5OEhMQkFrYXVCN050VTVvZXBjNlpISEszSktiVkNRcUpVcHc1UTdsdklwOW…
BCAT - BlackRock Capital Allocation Term Trust Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE5RaGMyU3RkVkRkOG12TC01czdnbXNjbldsQlBQUGNpZmw1SkJ5NHJWQzg2QTBYaWozSzB6dXA1ZTd2Y0s1NHc?oc=5" target="_blank">BCAT - BlackRock Capital Allocation Term Trust Stock Price and Quote</a>…
BlackRock Capital Allocation Term Trust to Issue Monthly Dividend of $0.25 (NYSE:BCAT) - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPXzcxVWtiT2ZHRThMLUNvYk5rX01ENm1sb0Z2cmZaT0RMeS1iY09VQlpYeXdoS2lIMnF5Qkpta0l1OHNkUWtxOWlmMGVYUzJ4dURSQjVzN29Oa3ZfUl9rd3M5dHpFcVhzd1Z0RWdraGFsTEpXLUVoczE1cVNWY0hVWWZTNGxsNUNjY1V4ZX…
Interest paid of BlackRock Capital Allocation Term Trust – NYSE:BCAT - TradingView
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNYW9jY1E0MVRnanI0aXVBaUdDZzZtUGJSOWJfTURJeU1vX3VnOU1rYS00U2NuTm92R0pGYnJieS1PRlp4TDBxR18tMlVMbk5LcmRneTBnVkcyV1MybW5kNkFid0RxbjZ2MTlJa2dBVkpTNmEtZjVnY0RxTzM3alpDdzVYZWtLaWhCQVU2VV…
BCAT — Frequently Asked Questions
What is the current share price of BCAT?
As of 2026-09-07 16:24 PDT, BCAT trades at $16.00 on NASDAQ/NYSE. Its 52-week range is $11.88 to $16.05.
What is the market capitalisation of BCAT?
BCAT has a market capitalisation of $1.68B on NASDAQ/NYSE.
What is the P/E ratio of BCAT?
BCAT trades at a trailing price-to-earnings (P/E) ratio of 8.74. Its price-to-book (P/B) ratio is 1.05.
What is the return on equity (ROE) of BCAT?
BCAT has a return on equity (ROE) of 13.92%.
Is BCAT a good stock to buy?
This page provides a data-driven analysis of BCAT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.